CX DAILY

CX Daily: Chinese Biotech Is Having a ‘DeepSeek Moment’

Published: Jun. 17, 2025 9:20 a.m. GMT+8

00:00

00:00/00:00

Listen to this article 1x

TOP STORY

Drugs /

Cover Story: Chinese biotech is having a ‘deepseek moment’

In a resounding vote of confidence in China’s biotechnology sector, leading global pharmaceutical companies are striking multibillion-dollar deals for innovative therapies developed by Chinese firms. These deals mark a pivotal point for China’s role in global drug development and have sparked a capital market frenzy.

Register to read this article for free.

Register

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Save an extra $50. Introductory offer for new readers. Subscribe now.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Huaiyang Cuisine Takes Center Stage at Trump Banquet

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

China Business Uncovered Podcast: Inside Vanke and China’s Property Reckoning

00:00

00:00/00:00

MOST POPULAR

1: Cover Story: China’s AI Boom Is Rewiring Its Power Grid

2: China Auditor Exposes Local Governments Faking Debt Cleanups

3: Iran Clears Chinese Cargo Ships as Strait of Hormuz Sees Chaotic Reopening

4: China Rolls Out 15-Point Plan to Woo Foreign Capital

5: Chinese Business Group Urges EU to Ease New Foreign Investment Restrictions

SPONSORED

OR